PMTCT Service Uptake among Adolescents and Adult Women Attending Antenatal Care in Selected Health Facilities in Zimbabwe

Musarandega, R., Machekano, R., Chideme, M., et al.

To understand the uptake of HIV services by adolescent women, the authors conducted a retrospective analysis of patient-level data (2011–2013) on services for antenatal care (ANC) and prevention of mother-to-child transmission (PMTCT) in 36 facilities in 5 districts in Zimbabwe. Zimbabwe's Option A policy encourages pregnant women to attend ANC before 14 weeks gestation and to begin antiretroviral therapy (ART) if eligible. The authors compared service uptake by 22,215 adolescent (19 years). Adolescents (22.5% of the total) were 34 percent more likely to present to ANC before 14 weeks gestational age than older women; just over one-third of both adolescents and adults completed the four recommended visits. Acceptance of HIV testing was high in both groups (>95%). HIV prevalence was 5.5 percent in adolescents versus 20.1 percent in adults. While the majority of both HIV-positive groups received antiretrovirals for PMTCT (84%), fewer eligible adolescents than adults were initiated on ART (44% versus 51.3%), though the difference was not statistically significant. Pregnant adolescents must be a priority for primary HIV prevention services and expanded HIV treatment services among pregnant women to achieve an AIDS-free generation in Zimbabwe and similar high-HIV burden countries.

April 6, 2017
Year of publication
Resource types
Journal and research articles
uptake of services, PMTCT, prevention of mother-to-child transmission (PMTCT), adolescent girls, antenatal care, Zimbabwe, Option A, pregnant women, treatment, ART, antiretroviral therapy, HIV testing, pregnant adolescents

Similar Resources

Remarkable progress is being made on HIV treatment. Ahead of World AIDS Day, UNAIDS has launched a new report showing that access to treatment has risen significantly. In 2000, just 685 000 people living with HIV had access to antiretroviral therapy.

Timely access to antiretroviral treatment (ART) is vital to ensuring safe motherhood and reducing vertical transmission. Treatment guidance and programming has changed dramatically in recent years.

This study aimed to evaluate the impact of clinic-based prevention of mother-to-child transmission (PMTCT) community support by trained lay health workers in addition to standard clinical care on PMTCT infant outcomes.

This paper documents the development of the global and national monitoring and reporting systems for PMTCT and paediatric HIV care and treatment programmes, achievements and remaining challenges.

Many countries are working to reduce or eliminate mother-to-child transmission (MTCT) of HIV. Prevention efforts have been conceptualized as steps in a cascade but cascade completion rates during and after pregnancy are low.

An essential first step in caring for HIV-infected children is accurate and early diagnosis of HIV, early HIV testing, prompt return of results, and rapid initiation of treatment.

In 2013, Uganda updated its prevention of maternal-to-child transmission of HIV program to Option B+, which requires that all HIV-infected pregnant and breastfeeding women be started on lifelong antiretroviral therapy (ART) regardless of CD4 count…

Option B+ for prevention of mother-to-child transmission (PMTCT) specifies treating all HIV-positive women with antiretroviral therapy (ART) regardless of CD4 count. This simplified approach enhances countries' capacity to reach national HIV targets and contribute to the global 90-90-90 goals.…

Female sex workers (FSW) in sub-Saharan Africa have a higher prevalence of HIV than other women of reproductive age. Social, legal, and structural barriers influence their access to care. Little is known about the HIV diagnosis and care cascade in most countries in southern Africa.

This article is featured in the SHARE Research Digest. Click here to learn more.